Stone Ridge Asset Management’s Integra LifeSciences IART Stock Holding History

Stone Ridge Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-6,948	Closed	-$310K	–	677
2020 Q1	$310K	Sell	6,948 -25,200	-78%	-$1.32M	0.03%	506
2019 Q4	$1.87M	Buy	32,148 +2,300	+8%	+$137K	0.11%	220
2019 Q3	$1.79M	Buy	29,848 +5,200	+21%	+$310K	0.11%	229
2019 Q2	$1.38M	Buy	24,648 +13,000	+112%	+$669K	0.08%	296
2019 Q1	$649K	Buy	+11,648	New	+$593K	0.04%	609
2018 Q2	–	Sell	-7,526	Closed	-$416K	–	1284
2018 Q1	$416K	Hold	7,526	–	–	0.02%	881
2017 Q4	$360K	Buy	+7,526	New	+$368K	0.02%	971

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Stone Ridge Asset Management's IART Position: Q2 2020 in Review

Stone Ridge Asset Management sold out of Integra LifeSciences (IART) in Q2 2020, closing a stake of 6,948 shares — an estimated $310K sold.

Stone Ridge Asset Management first reported a position in IART in Q4 2017 and held it in 7 quarters. The position peaked at $1.87M in Q4 2019. 264 funds tracked by Wall St. Rank hold IART as of Q2 2020.

Stone Ridge Asset Management reported no remaining Integra LifeSciences position as of Q2 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 6,948 Integra LifeSciences shares in Q2 2020, an estimated $310K.
Stone Ridge Asset Management first reported a position in Integra LifeSciences in Q4 2017 and held it in 7 quarters.
Stone Ridge Asset Management's Integra LifeSciences position peaked at $1.87M in Q4 2019.
264 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2020.

Based on Stone Ridge Asset Management's 13F filing for Q2 2020, filed 23 Jul 2020.